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Abstract
Background: Impaired gastric emptying is common in critically ill patients. Intestinal dysmotility, a major cause of
feed intolerance, may foster infectious complications due to mucosal barrier disruption. However, little is known
about gut-directed immune activation, intestinal barrier function and its association with impaired gastric emptying
in critically ill patients at ICU admission.
Methods: We conducted a prospective observational study at two tertiary care medical ICUs. Fifty consecutive
patients needing invasive mechanical ventilation were recruited within 24 h of ICU admission, prior to any
nutritional support. The acute physiology and chronic health evaluation (APACHE) II score, the sequential organ
failure assessment (SOFA) score and the multiple organ dysfunction score (MODS) were used to assess illness
severity and multiple organ dysfunction. Gastric emptying was assessed by paracetamol absorption test. Peripheral
blood mononuclear cells were freshly isolated and cultured for 24 h, and TNF-α, IL-1β and IL-10 measured in cell
culture supernatants and in serum by ELISA. The intestinal epithelial barrier was assessed, quantifying serum
concentrations of intestinal fatty acid binding protein (I-FABP), ileal bile-acid binding protein (I-BABP) and zonulin-1
by ELISA. Small bowel homing T lymphocytes (CD4+ α4β7 + CCR9+) were analyzed by flow cytometry. The Mann-
Whitney test and Spearman correlation were used in statistical evaluation.
Results: CD4 + α4β7 + CCR9+ T lymphocytes were inversely correlated with gastric emptying. Patients with delayed
gastric emptying at ICU admission (n = 35) had significantly higher serum and PBMC-induced TNF-α and IL-1β and
increased intestinal barrier disruption reflected by higher I-FABP, I-BABP and zonulin-1. Patients who died in the ICU
had significantly impaired gastric empting at admission compared to ICU survivors. No differences were observed in
APACHE II, SOFA or MODS in patients with delayed gastric emptying compared to patients with normal gastric
emptying.
Conclusions: Exaggerated CD4 + α4β7 + CCR9+ T lymphocyte homing with increased pro-inflammatory cytokine
release and intestinal epithelial barrier disruption are associated with delayed gastric emptying. This is not simply
due to differences in overall severity of illness at ICU admission and may represent a pathophysiological mechanism
of gut-directed immune activation leading to impaired barrier function in the critically ill.
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Background
Enteral nutrition via the gastrointestinal tract is accepted
to improve health outcomes in critically ill patients [1].
Gastrointestinal motility disorders, in particular im-
paired gastric emptying frequently impede enteral nutri-
ent delivery. The advantages of enteral nutrition include
a decrease in infectious complications and mucosal bar-
rier protection against bacterial translocation [2, 3]. The
highest incidence of delayed gastric emptying in the crit-
ically ill has been reported in patients with sepsis [4].
The intestine participates in the inflammatory re-
sponse locally with cytokine production and leukocyte
recruitment. To perform their immunological functions,
T lymphocytes must exit the blood and enter into differ-
ent tissues in the body. Recruitment of leukocytes during
an inflammatory response involves the expression and
activation of adhesion molecules. CD4+ T lymphocytes
responding to the antigen in intestinal lymph nodes start
to express high levels of the integrin α4β7 and the che-
mokine receptor CCR9. The intestinal ligand of CCR9 is
CCL25 and it is mainly expressed in the mucosal epithe-
lium of the small intestine. Thus, co-expression of α4β7
and CCR9 delineates a subset of T lymphocytes prefer-
entially migrating to the lamina propria of the small
intestine [5].
While we have previously identified association between
CD4 + α4β7 + CCR9+ T lymphocytes and gastric empty-
ing [6], we hypothesized that CD4 + α4β7 + CCR9+ T
lymphocytes are associated with enhanced pro-
inflammatory cytokine secretion, intestinal barrier disrup-
tion and delayed gastric emptying in the critically ill.
While assessment of gastrointestinal permeability by the
frequently applied sugar absorption tests are not reliable
in ICU patients [7] we choose to quantify plasma zonulin,
ileal bile acid binding protein (ileal bile-acid binding pro-
tein) and intestinal fatty acid binding protein (intestinal
fatty acid binding protein). Scintigraphy is considered the
gold standard for evaluation of gastric emptying. Unfortu-
nately, all currently available tests for the assessment of
gastrointestinal motility, including scintigraphy, have lim-
ited value in the ICU setting. Major obstacles include
lengthy procedures, the need to transfer patients, lack of
accuracy in multi-organ dysfunction, costs and availability
[8]. In the present prospective observational study, we
have chosen the paracetamol absorption test for the as-
sessment of gastric emptying as it is a feasible and reliable
technique in the ICU setting [9, 10].
Methods
Study population
Fifty consecutive critically ill patients with immediate
need of invasive mechanical ventilation were recruited
within 24 h of ICU admission. A blood sample was
drawn from these patients for cell isolation, serum
cytokine ELISA and t0 paracetamol concentration meas-
urement followed by immediate application of paraceta-
mol for assessment of gastric emptying. None of these
patients received any enteral or parenteral nutritional
support within 24 h of ICU admission. Patients receiving
any pro-kinetic drug within 7 days prior to admission
were not included.
The leading cause of ICU admission was sepsis, acute
respiratory failure or cardiac failure (Table 1). Patients
with an underlying malignancy and relapse or disease
progression or hematopoietic stem cells recipients with
acute graft versus host disease were not included. No
surgical or postoperative patients were included. The
study was approved by the University Hospital Essen
Human Ethics Committee and conducted in accordance
with the World Medical Association Declaration of
Helsinki. Informed consent was obtained from each pa-
tient’s next of kin. In addition eligibility for study partici-
pation was confirmed by an independent physician.
ICU severity scores
Severity of illness was assessed by the acute physiology
and chronic health evaluation (APACHE) II score and
the severity of multiple organ dysfunction was assessed
by sequential organ failure assessment (SOFA) and the
multiple organ dysfunction score (MODS).
Gastric emptying
Gastric emptying was assessed by the paracetamol ab-
sorption test [9]. Briefly, 2 g paracetamol was admin-
istered with 20 ml water via a nasogastric tube. Blood
samples were drawn a time (t) = 0, 15, 30, 60, 90 and
120 minutes to measure paracetamol levels deter-
mined by the enzymatic degradation method. The
area under the concentration curve from 0 to 60 mi-
nutes (AUC60) was used as the measure of gastric
emptying. An AUC <600 min*mg/l was considered as
delayed gastric emptying [9].
Cell isolation and culture conditions
For the following cell culture and ELISA experiments in-
vestigators were blinded to study subject details, including
diagnosis, age and gender. Peripheral blood mononuclear
cells (PBMC) were freshly isolated by density gradient
centrifugation. Diluted blood (1:2 in RPMI 1640 medium)
was layered onto Ficoll-Hypaque (Sigma, Castle Hill,
NSW, Australia) and centrifuged at 400 g for 15 minutes.
PBMC were washed twice with sterile PBS and viability
was assessed by trypan blue exclusion. PBMC were re-
suspended to 1 × 106 cells/ml in complete medium (RPMI
1640 medium (Gibco, Karlsruhe, Germany), supple-
mented with 10% fetal calf serum, 100 U/ml penicillin,
0.1 mg/ml streptomycin and L-Glutamine). PBMC were
cultured in 24-well plates for 24 h.
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ELISA
Serum and cell-free culture supernatants were collected,
diluted in the supplied dilution buffer or 1:1 in RPMI
medium and stored at -80 °C until assayed. TNF-α, IL-
1β and IL-10 were quantified using ELISA kits
(eBioscience, San Diego, CA, USA) according to the
manufacturer’s instructions with minor modifications.
Human I-FABP (Hycultbiotech, Beutelsbach, Germany),
Zonulin and I-BABP (Cusabio, Wuhan, China) were ana-
lyzed utilizing commercially available ELISA kits. Optical
density was measured at a wavelength of 450 nm and a
reference wavelength of 590 nm. Density values were
linearly correlated with the concentrations of test
standards.
Flow cytometry
To identify small bowel homing T lymphocytes freshly
isolated PBMC (105) were labeled with previously deter-
mined optimal concentrations of monoclonal antibodies
directed against human CD3 (APC; eBioscience), CD4
(PerCp; eBioscience), CD49d (α4-Integrin) (FITC; BioLe-
gend), β7-Integrin (PE; BioLegend) and CCR9 (Alexa647;
BioLegend). Matching IgG1 and IgG2a conjugated anti-
bodies served as isotype controls. Cells were incubated
with the antibodies for 30 minutes on ice and washed
three times in FACS buffer between each step. Nonspe-
cific binding of antibodies was minimized by 10-minute
incubation of cell suspensions with pooled human serum
(10%) in fluorescence-activated cell sorting (FACS) buf-
fer before addition of the first antibody. After washing
twice, cells were re-suspended in 100 μl of 1% parafor-
maldehyde in PBS and analyzed utilizing a Beckman
Coulter Navios. Lymphocyte populations were gated
based on forward scatter/side scatter properties. A total
of 3 × 104 events were routinely collected and analyzed.
Data analysis
The non-parametric Wilcoxon rank-sum test was used
to evaluate differences between groups according to nor-
mal and delayed gastric emptying reflected by paraceta-
mol absorption below or above 600 min*mg/l and ICU
survival. Data are expressed as median, 95% confidence
interval; throughout the manuscript, n represents the
number of subjects. The relationship between CD4
+ α4β7 + CCR9+ T lymphoctyes and paracetamol ab-
sorption was assessed by Spearman rank correlation. In
all cases p values <0.05 were considered significant. SPSS
Version 12 (Statistical Package for Social Sciences,
Chicago, I, USA) was used for the statistical analysis.
Results
Patient characteristics
Patient demographics are displayed in Table 1. Dosage
of vasoactive drugs, inotropes and sedative or analgesic
Table 1 Patient characteristics
Delayed gastric
emptying
(n = 35)
Normal gastric
emptying
(n = 15)
Demographics
Age (years) 58.4 ± 15.2 62.1 ± 11.4
Gender (male/female), n 17/18 8/7
Body mass index (kg/m2) 27.6 ± 7.3 27.3 ± 6.2
Admission diagnosis, n (%)
Sepsis 13 (37) 7 (47)
Acute respiratory failure 12 (34) 5 (33)
Cardiac failure 10 (29) 3 (20)
Underlying condition
Hematologic malignancies, n (%) 17 (49) 7 (47)
➢ Acute myeloid leukemia 11 (64) 4 (58)
➢ Lymphoma (B cell) 2 (12) 1 (14)
➢ Myelodysplasia 2 (12) 1 (14)
➢ Myeloproliferative disease 1 (6) 1 (14)
➢ Multiple myeloma 1 (6) 0
Solid tumors 5 (14) 4 (26)
HSCT 4 (11) 1 (7)
Cardiac ischemia 6 (17) 2 (13)
Solid organ transplant 3 (9) 1 (7)
Renal function, n (%)
Failure 16 (46) 6 (40)
Renal replacement therapy 9 (26) 5 (33)
Biochemistry
Serum bilirubin level (mg/dl) 1.4 ± 1.8 0.9 ± 0.7
White blood cell count (/nl) 8.8 ± 6.4 10.8 ± 7.1
Serum creatinine (mg/dl) 1.2 ± 1.4 0.9 ± 1.1
Glycemic control
Blood glucose level (mg/dl) 124.0 ± 39.0 143.3 ± 24.1
Insulin (IE/h) 2.6 ± 5.3 1.8 ± 2.2
Medications, n (%)
Sufentanil 35 (100) 15 (100)
Midazolam 26 (74) 11 (73)
Propofol 9 (26) 4 (27)
Vasoactive drugs 23 (66) 12 (80)
Inotropes 10 (29) 5 (33)
Mechanical ventilation
Pao2/Fio2 ratio 213.2 ± 76.4 229.1 ± 96.2
Peak inspiratory pressure (mmHg) 22.6 ± 4.9 23.3 ± 3.2
Positive end-expiratory pressure
(mmHg)
7.8 ± 2.9 7.7 ± 2.8
ICU length of stay (days) 33.8 ± 30.1 24.7 ± 18.1
Results are presented as mean ± SD or number (percentage). HSCT allogeneic
hematopoietic stem cell transplantation, Pao2/Fio2 partial arterial oxygen
pressure/fraction of inspired oxygen
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agents did not differ significantly between patients with
and without delayed gastric emptying. No differences
were observed in age, gender, body mass index (BMI),
biochemical measurements, glycemic control or mech-
anical ventilation parameters. All patients were initially
ventilated with biphasic positive airway pressure. Pa-
tients with and without delayed gastric emptying did not
differ in the incidence of acute renal failure or need of
continuous renal replacement therapy.
Gastric emptying
There were 35 patients (70%) with impaired paracetamol
absorption, which was used as a measure of delayed gas-
tric emptying at ICU admission. Gastric emptying was
significantly (p = 0.004) different (Fig. 1) in patients who
died in the ICU (AUC 323.8 ± 48.1) compared to ICU
survivors (647.4 ± 93.5). Overall mortality in the ICU
was 50%.
ICU severity scores
There were no significant differences in the APACHE II
(27.5, 95% CI 18.0–34.0 vs. 24.0, 95% CI 19.0–30.0; p =
0.180), SOFA (10.0, 95% CI 5.0–17.0 vs. 10.0, 95% CI
4.0–19.0; p = 0.840) or MODS (9.0, 95% CI 5.0–13.0 vs.
9.0, 95% CI 4.0–17.0; p = 0.380) in patients with delayed
gastric emptying compared to patients with normal gas-
tric emptying (Fig. 2).
Small bowel homing T lymphocytes
CD4 + α4β7 + CCR9+ T lymphocytes were inversely cor-
related (r = -0.5; p = 0.001) with gastric emptying as
reflected by paracetamol absorption (Fig. 3).
Cytokines
Patients with delayed gastric emptying had significantly
enhanced serum TNF-α (54.0 pg/ml, 95% CI 13.0–127.9
vs. 28.2 pg/ml, 95% CI 21.8–48.4; p = 0.022) and IL-1β
(98.5 pg/ml, 95% CI 37.0–182.6 vs. 212.2 pg/ml, 95% CI
91.0–548.6; p = 0.005) compared to patients with normal
gastric emptying. Release of PBMC-mediated TNF-α
(86.5 pg/ml, 95% CI 17.4–342.2 vs. 41.5 pg/ml, 95% CI
31.9–98.6; p = 0.020) and IL-1β (280.4 pg/ml, 95% CI
94.0–412.5 vs. 124.6 pg/ml, 95% CI 85.3–247.3; p =
0.001) was significantly augmented in patients with de-
layed gastric emptying. No significant differences in IL-
10 were observed (Fig. 4).
Fig. 1 Paracetamol absorption in ICU survivors compared to non-
survivors. Patients who died in the ICU had significantly lower
paracetamol absorption (p = 0.004). AUC area under the curve
Fig. 2 Severity of illness reflected by the acute physiology and
chronic health evaluation (APACHE) II score, severity of multiple
organ dysfunction assessed by the sequential organ failure assessment
(SOFA) or the multiple organ dysfunction score (MODS) in patients with
delayed (area under the curve (AUC) <600 min*mg/l) and normal
gastric emptying (AUC ≥600 min*mg/l)
Fig. 3 Percentage of CD4 + α4β7 + CCR9+ T lymphocytes was
inversely correlated (r = -0.5; p = 0.001) with gastric emptying as
reflected by paracetamol absorption (area under the curve
(AUC) min*mg/l)
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Mucosal integrity
Delayed gastric emptying was associated with signifi-
cantly enhanced zonulin (10.4 ng/ml, 95% CI 0.5–59.0
vs. 2.5 ng/ml, 95% 0.6–4.9; p = 0.020), I-BABP 3.7 ng/ml,
95% CI 0.7–7.8 vs. 1.0 ng/ml, 95% CI 0.6–1.3; p = 0.015)
and I-FABP (592.0 pg/ml, 95% CI 218.0–975.0 vs.
244.5 pg/ml, 95% CI 180.0–567.0; p = 0.009) (Fig. 5).
Discussion
The inability of enteral feeding due to delayed gastric
emptying frequently necessitates total parenteral nutri-
tion. Total parenteral nutrition itself leads to mucosal
inflammatory response resulting in a loss of epithelial
barrier function [2], further contributing to intestinal
motility disturbances. Increased intestinal permeability
predicts the development of multiple organ failure and
early enteral nutrition is a key factor for preservation of
gut barrier function reducing the risk of organ failure
[11]. Furthermore, enterocyte damage has been reported
to be associated with ICU mortality [12].
While in most studies feed-intolerant patients or pa-
tients receiving parenteral nutrition have been examined,
we investigated immune activation with epithelial barrier
dysfunction and gastric emptying at admission prior to
any enteral or parenteral nutritional support. Zonulin in-
creases intestinal permeability in the epithelia of the
small intestine and increased plasma zonulin has been
reported in sepsis [13]. I-FABP is particularly expressed
in the jejunum and if released into plasma indicates
enterocyte destruction [14, 15], while I-BABP is exclu-
sively present in the ileum [16]. We identified increased
Zonulin, I-BABP and I-FABP levels in patients with de-
layed gastric emptying, indicating marked differences in
upper gastrointestinal mucosal barrier integrity at the
onset of critical illness.
In our study patients with delayed gastric emptying
had significantly higher CD4 + α4β7 + CCR9+ T lympho-
cytes compared to patients with normal gastric emptying
at ICU admission. Indeed CCR9 is required for effector
CD4+ T lymphocyte entry into small intestinal lamina
propria [17]. Under inflammatory conditions intra-
epithelial lymphocytes alter barrier function, conse-
quently enhancing intestinal permeability and further
enhancing chemokine production [18]. In particular,
IFABP and IBAP were inversely correlated with gastric
emptying, indicating small bowel immune activation
with intestinal barrier alterations associated with gastric
emptying. There is further evidence linking intestinal
immune activation with CD4 + α4β7 + CCR9+ T lym-
phocytes and gastrointestinal motility. The detection of
CCR9-expressing T lymphocytes in the bloodstream of
patients with post-operative ileus has been reported to
potentially reflect dysmotility [19].
Apart from increased CD4 + α4β7 + CCR9+ T lympho-
cytes, we also identified increased serum cytokine levels
and pro-inflammatory cytokines produced in vitro by
PBMC. Intestinal dysmotility is known to be accompan-
ied by increased expression of pro-inflammatory
Fig. 4 TNF-α and IL-1β (pg/ml) in peripheral blood mononuclear cell culture supernatants and serum of patients with delayed gastric
emptying (area under the curve (AUC) <600 min*mg/l) and normal gastric emptying (AUC ≥600 min*mg/l). Error bars range, bold line median, box
5th–95th centiles)
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cytokines such as TNF-α and IL-1β, followed by infiltra-
tion of lymphocytes [20]. Based on animal models, TNF-
α and IL-1β are known to directly inhibit gastric
emptying [21] and decrease small bowel muscle con-
tractility [22]. The increased release of pro-inflammatory
cytokines is followed by infiltration of T lymphocytes
and macrophages [23]. Macrophages activated by CD4+
T lymphocytes in the intestine initiate the release of ni-
tric oxide, directly inhibiting smooth muscle cell
function [24] consequently contributing to intestinal
dysmotility. In a previous study, both cytokines were en-
hanced in patients with idiopathic gastroparesis even in
the absence of an infectious stimulus [6]. Thus, our data
clearly suggest an association between increased pro-
inflammatory cytokines with delayed gastric emptying in
the critically ill. Furthermore, TNF-α is a critical factor
for epithelial barrier dysfunction [25]. A significant in-
crease in TNF-α in bowel segments is linked to an im-
paired epithelial barrier [3] within these segments. We
therefore believe that our findings of enhanced epithelial
barrier function reflected by increased zonulin, I-BABP
and I-FABP in subjects with delayed gastric emptying
depict a putative causal link between initial immune ac-
tivation and gastric dysmotility.
Utilizing the paracetamol absorption test, we found
70% of patients, who were admitted to the ICU and
needed immediate invasive mechanical ventilation, had
impaired gastric emptying. This is in line with published
data showing delayed gastric emptying in 42–81% of
ICU patients [26, 27]. While the diagnosis on admission
exerts a modest impact on gastric emptying in the critic-
ally ill, it appears to be most prominent in sepsis. In-
deed, the majority of patients included in the present
study were admitted to ICU with an infectious complica-
tion leading to sepsis or acute respiratory failure. Against
the background of published data demonstrating an as-
sociation between gastric emptying and severity of ill-
ness [4] it could be argued that the observed differences
in immune activation and epithelial barrier function pa-
rameters between patients with normal and delayed gas-
tric emptying are simply a function of baseline severity
of illness. However, we did not observe differences in the
APACHE II, MODS or SOFA in our study population.
Other potentially confounding factors include sedation
and glycemic control. It has been demonstrated that pa-
tients receiving morphine and midazolam are more
likely to have slow gastric emptying than those receiving
propofol [28]. The majority of the patients included in
our study received midazolame and sufentanil, without
significant differences between the groups. However, an
effect of sedation on the overall rate of delayed gastric
emptying cannot be excluded. There is abundant litera-
ture on glycemic control in the critically ill and blood
glucose concentration could be one of a number of fac-
tors affecting gastric emptying [29]. Our patients had
comparable blood glucose levels and equal insulin doses
to achieve glycemic control. Therefore, a profound effect
on gastric emptying cannot be assumed.
It also needs to be acknowledged that the majority of
patients in our study had an underlying malignancy. There
are some data indicating T lymphocyte dysfunction in pa-
tients with hematologic malignancies, potentially differing
from the general population of critically ill patients.
Fig. 5 Serum concentration of zonulin-1 (ZO-1), intestinal fatty acid
binding protein (I-FABP) and ileal bile acid binding protein (I-BABP) in
patients with delayed gastric emptying (area under the curve (AUC)
<600 min*mg/l) and normal gastric emptying (AUC ≥600 min*mg/l).
Error bars, bold line and box respectively represent range, median
and 5th-95th centiles Error bars range, bold line median, box
5th–95th centiles)
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Different degrees of T lymphocyte dysfunctionality, in-
cluding impaired proliferation, altered cytokine secretion
and altered expression of surface molecules, have been de-
scribed in various hematologic malignancies. In particular
T cell lymphoma, chronic myeloid leukemia and chronic
lymphoid leukemia are known to be associated with T
lymphocyte dysfunctionality. The invasive spreading abil-
ity of leukemic cells may depend on the expression of sur-
face molecules including α4β7-Integrin.
There are limited data on neoplastic cells in T cell
lymphoma, not achieving remission, expressing α4β7-
Integrin when infiltrating bone marrow [30]. Increased
expression of α4β7-Integrin is also observed in
hematopoietic stem cell recipients with acute gastrointes-
tinal graft versus host disease [31]. Therefore, it needs to
be emphasized that we did not include patients with re-
lapse, disease progression or acute graft versus host disease
in this study. In addition, the majority of patients with an
underlying hematological malignancy had acute myeloid
leukemia, which is not associated with a T lymphocyte
proliferation defect or impairment of cytokine secretion
[32]. Furthermore patients in remission or patients who
have undergone intensive chemotherapy may have reduced
CD4+ T lymphocytes but without impairment of prolifera-
tion [33]. Only when T lymphocyte counts are very low
are the remaining T lymphocytes functionally impaired.
Thus, it is important to emphasize that patients in our
study had normal white blood cell counts and T lympho-
cyte populations and therefore do not represent severely
neutropenic (<1.500 neutrophils/μl) patients with cancer,
whose inclusion could potentially confound the immune
activation results. However, the observed ICU mortality of
50% reflects current mortality rates of critically ill patients
with cancer [34] and is therefore certainly due to the high
percentage of patients in our study who had malignancies.
Conclusions
To our knowledge this study is the first to identify a link
between gastric dysmotility and increased small bowel-
directed immune activation and mucosal barrier impair-
ment in ICU patients at the onset of critical illness, in
the absence of any nutritional support. Our result sug-
gests that initial immune activation leads to increased
release of pro-inflammatory cytokines followed by infil-
tration of lymphocytes. While cytokines are able to dir-
ectly impair gastrointestinal motility, lymphocytes may
contribute to delayed gastric emptying by activating
macrophages releasing nitric oxide as a motility inhibi-
tor. Cytokines also impair intestinal permeability, leading
to amplification of the inflammatory response. Thus, this
cascading inflammation may drive organ failure includ-
ing impaired intestinal barrier and motility as an under-
lying cause of further intestinal dysfunction, regardless
of the overall severity of the initial illness.
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